Skip to content
Home/Research/GHRP-2

GHRP-2 Research & Studies

We track 20 published, PubMed-indexed studies for GHRP-2, spanning 1995 to 2025. The research below includes 3 research articles, 5 reviews, 12 clinical trials.

These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
3
Research Articles
5
Reviews
12
Clinical Trials

Growth Hormone-Releasing Peptide 2 May Be Associated With Decreased M1 Macrophage Production and Increased Histologic and Biomechanical Tendon-Bone Healing Properties in a Rat Rotator Cuff Tear Model.

Research Article
Li Y, Yao L, et al.|Arthroscopy|2025

Robust growth hormone responses to GH-releasing peptide 2 in adolescents.

Research Article
Onuki T, Hiroaki T, et al.|J Pediatr Endocrinol Metab|2024

On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse.

Research Article
Reverter-Branchat G, Segura J, Pozo OJ|Drug Test Anal|2021

Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.

Review
Sinha DK, Balasubramanian A, et al.|Transl Androl Urol|2020

The Safety and Efficacy of Growth Hormone Secretagogues.

Review
Sigalos JT, Pastuszak AW|Sex Med Rev|2018

Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation.

Clinical Trial
Hu R, Wang Z, et al.|PLoS One|2016

Adult growth hormone deficiency: current concepts.

Review
Fukuda I, Hizuka N, et al.|Neurol Med Chir (Tokyo)|2014

Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH agonist/testosterone clamp.

Clinical Trial
Veldhuis JD, Bowers CY|J Clin Endocrinol Metab|2009

Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.

Clinical Trial
Veldhuis JD, Bowers CY|Am J Physiol Endocrinol Metab|2009

Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.

Review
Unknown|Drugs R D|2004

The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.

Clinical Trial
Van den Berghe G, Baxter RC, et al.|Clin Endocrinol (Oxf)|2002

Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.

Clinical Trial
Arvat E, Di Vito L, et al.|J Endocrinol Invest|1999

Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.

Clinical Trial
Van den Berghe G, Wouters P, et al.|Eur J Endocrinol|1999

Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children.

Clinical Trial
Pihoker C, Kearns GL, et al.|J Clin Endocrinol Metab|1998

Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.

Clinical Trial
Pihoker C, Badger TM, et al.|J Endocrinol|1997

The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.

Clinical Trial
Van den Berghe G, de Zegher F, et al.|J Clin Endocrinol Metab|1997

Growth hormone-releasing peptides.

Review
Ghigo E, Arvat E, et al.|Eur J Endocrinol|1997

Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.

Clinical Trial
Van den Berghe G, de Zegher F, et al.|Clin Endocrinol (Oxf)|1996

GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans.

Clinical Trial
Bowers CY, Granda-Ayala R|J Pediatr Endocrinol Metab|1996

Growth hormone (GH)-releasing effects of synthetic peptide GH-releasing peptide-2 and GH-releasing hormone (1-29NH2) in children with GH insufficiency and idiopathic short stature.

Clinical Trial
Tuilpakov AN, Bulatov AA, et al.|Metabolism|1995